- Report
- April 2025
- 175 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- March 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- June 2022
- 215 Pages
United States
From €2457EUR$2,699USD£2,086GBP
Adacel is a vaccine market that focuses on the development and production of vaccines for the prevention of infectious diseases. It is a rapidly growing market, driven by the need to protect people from a wide range of illnesses. Adacel vaccines are designed to stimulate the body's immune system to produce antibodies that can fight off the disease-causing agent. The vaccines are typically administered through injection, although some may be administered orally or nasally.
Adacel vaccines are used to protect against a variety of illnesses, including influenza, measles, mumps, rubella, and hepatitis B. They are also used to protect against certain types of cancer, such as cervical cancer. Adacel vaccines are typically administered to children and adults, although some may be used in specific populations, such as pregnant women.
The Adacel market is highly competitive, with many companies offering a range of vaccines. Some of the major players in the market include GlaxoSmithKline, Merck, Sanofi Pasteur, Pfizer, and Novartis. These companies are involved in the research, development, and production of Adacel vaccines, as well as the marketing and distribution of the vaccines. Show Less Read more